The EORTC Melanoma Group meeting will be held on 25 March 2022 from 09:00-17:00 CET and is only open to individual or site staff members of the group. Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Melanoma [...]

  Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients Brussels, Belgium; Castres, France (29 June 2021) – European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma. The [...]

The EORTC Melanoma Group meeting will be held on 1 October from 09:00-17:00 CEST and is only open to individual or site staff members of the group. Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Melanoma Group, [...]

The EORTC Melanoma Group Virtual meeting will be held on 12 March from 08:50 to 17:50 CET and is only open to individual or site staff members of the group. Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the [...]

PROGRAMME PLEASE NOTE: Pre-registration is required and registration is by email invite only The login details will be shared with participants shortly before the webinar. Time: 14:00 CET – 18:00 CET Opening by Chair (‘5) – van Akkooi Matters Arising (‘5) – van Akkooi Published / presented studies (‘5) – HQ team EORTC 18081, EORTC [...]

Recently, EORTC Melanoma group has presented and published new data that has shown improved outcomes for cancer patients. First of all, EORTC 1325/Keynote 054 study (adjuvant pembrolizumab vs. placebo after complete resection of high-risk stage III melanoma) which was presented at ASCO 2020, showed new recurrence free survival (RFS) data with median 3-year follow-up, confirming [...]